Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Trastuzumab × Clear all

Phase

Phase 2 13 Phase 1/2 4 Phase 1 4 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 100 HER2-positive Breast Cancer 7 Stomach Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Inflammatory Breast Neoplasms 3 Esophageal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Invasive Breast Cancer 2 HER2-positive Metastatic Breast Cancer 2 HER2-positive Early Breast Cancer 2 Colonic Neoplasms 2 Biliary Tract Neoplasms 2 Solid Tumors 1 Resectable HER2-positive Breast Cancer 1 Patient Preference 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteitis Deformans 1 HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients 1 HER2-positive Gastric Cancer 1 HER2-positive Carcinoma of Breast 1 HER2-positive Advanced Breast Cancer 1 HER2+ Breast Cancer 1 HER2 Positive Early or Locally Advanced Breast Cancer 1 HER2 Positive Early Breast Cancer 1 Endometrial Neoplasms 1 Early-stage or Locally Advanced HER2-positive Breast Cancer 1 Early or Locally Advanced HER2-positive Breast Cancer 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 104 Leucovorin 97 Oxaliplatin 74 Bevacizumab 68 Irinotecan 57 Capecitabine 53 Cetuximab 34 Folfox protocol 27 Panitumumab 15 regorafenib 13 Drug Therapy 13 trifluridine tipiracil drug combination 12 Chemotherapy, Adjuvant 11 IFL protocol 9 Radiotherapy 8 Neoadjuvant Therapy 7 Floxuridine 7 Aspirin 6 pembrolizumab 5 XELOX 5 Levoleucovorin 5 Laparoscopy 5 dehydroftorafur 4 atezolizumab 4 Trifluridine 4 Octreotide 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 xaliproden 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253651 2026-03-16

MOUNTAINEER-03

Seagen Inc.

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡